1. Hu JX, Zhao CF, Chen WB, et al. Pancreatic cancer: a review of epidemiology, trend, and risk factors. World J Gastroenterol 2021; 27: 4298-321.
2.
Stoffel EM, Brand RE, Goggins M. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology 2023; 164: 752-65.
3.
McGuigan A, Kelly P, Turkington RC, et al. Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol 2018; 24: 4846-61.
4.
Grossberg AJ, Chu LC, Deig CR, et al. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J Clin 2020; 70: 375-403.
5.
Moffat GT, Epstein AS, O’Reilly EM. Pancreatic cancer-a disease in need: optimizing and integrating supportive care. Cancer 2019; 125: 3927-35.
6.
Nipp RD. Palliative and supportive care for individuals with pancreatic adenocarcinoma. Hematol Oncol Clin North Am 2022; 36: 1053-61.
7.
Park W, Chawla A, O’Reilly EM. Pancreatic cancer: a review. JAMA 2021; 326: 851-62. Erratum in: JAMA 2021; 326: 2081.
8.
Klose J, Ronellenfitsch U, Kleeff J. Management problems in patients with pancreatic cancer from a surgeon’s perspective. Semin Oncol 2021; 48: 76-83.
9.
Perinel J, Adham M. Palliative therapy in pancreatic cancer-palliative surgery. Transl Gastroenterol Hepatol 2019; 4: 28.
10.
Ashbell I, Agam N, Chocron Y, et al. Surgical palliation for pancreatic cancer. Harefuah 2022; 161: 383-9.
11.
Buchwald H, Buchwald JN. Metabolic (bariatric and nonbariatric) surgery for type 2 diabetes: a personal perspective review. Diabetes Care 2019; 42: 331-40.
12.
Sudlow AC, Le Roux CW, Pournaras DJ. Long-term outcomes of bariatric surgery in patients with diabetes. Expert Rev Endocrinol Metab 2020; 15: 141-6.
13.
Uhe I, Douissard J, Podetta M, et al. Roux-en-Y gastric bypass, sleeve gastrectomy, or one-anastomosis gastric bypass? A systematic review and meta-analysis of randomized-controlled trials. Obesity 2022; 30: 614-27.
14.
Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA 2020; 324: 879-87.
15.
Affinati AH, Esfandiari NH, Oral EA, Kraftson AT. Bariatric surgery in the treatment of type 2 diabetes. Curr Diab Rep 2019; 19: 156.
16.
Ji Y, Lee H, Kaura S, et al. Effect of bariatric surgery on metabolic diseases and underlying mechanisms. Biomolecules 2021; 11: 1582.
17.
Yarmush ML, D’Alessandro M, Saeidi N. Regulation of energy homeostasis after gastric bypass surgery. Annu Rev Biomed Eng 2017; 19: 459-84.
18.
Kornyushin OV, Bakhtyukov AA, Zorina II, et al. [The effect of different types of bariatric surgery on the metabolic and hormonal parameters in rats with decompensed form of type 2 diabetes mellitus.]. Adv Gerontol 2019; 32: 85-92.
19.
Pizzato M, Turati F, Rosato V, La Vecchia C. Exploring the link between diabetes and pancreatic cancer. Expert Rev Anticancer Ther 2019; 19: 681-7.
20.
Sharma S, Tapper WJ, Collins A, Hamady ZZR. Predicting pancreatic cancer in the UK Biobank Cohort using polygenic risk scores and diabetes mellitus. Gastroenterology 2022; 162: 1665-74.e2.
21.
Cai J, Chen H, Lu M, et al. Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis. Cancer Lett 2021; 520: 1-11.
22.
Sharma A, Kandlakunta H, Nagpal SJS, et al. Model to determine risk of pancreatic cancer in patients with new-onset diabetes. Gastroenterology 2018; 155: 730-9.e3.
23.
Dunne RF, Roeland EJ. The interplay among pancreatic cancer, cachexia, body composition, and diabetes. Hematol Oncol Clin North Am 2022; 36: 897-910.
24.
Roy A, Sahoo J, Kamalanathan S, et al. Diabetes and pancreatic cancer: exploring the two-way traffic. World J Gastroenterol 2021; 27: 4939-62.
25.
Dunne RF, Roeland EJ. The interplay among pancreatic cancer, cachexia, body composition, and diabetes. Hematol Oncol Clin North Am 2022; 36: 897-910.
26.
Rodríguez JI, Kutscher M, Lemus M, et al. Palliative gastrojejunostomy in unresectable cancer and gastric outlet obstruction: a retrospective cohort study. Ann R Coll Surg Engl 2021; 103: 197-202.
27.
Dang JT, Deprato A, Verhoeff K, et al. Variation of laparoscopic Roux-en-Y gastric bypass techniques: a survey of 518 bariatric surgeons. Obes Surg 2022; 32: 2357-65.
28.
Almby KE, Katsogiannos P, Pereira MJ, et al. Time course of metabolic, neuroendocrine, and adipose effects during 2 years of follow-up after gastric bypass in patients with type 2 diabetes. J Clin Endocrinol Metab 2021; 106: e4049-61.
29.
Katsogiannos P, Kamble PG, Wiklund U, et al. Rapid changes in neuroendocrine regulation may contribute to reversal of type 2 diabetes after gastric bypass surgery. Endocrine 2020; 67: 344-53.
30.
Feris F, McRae A, Kellogg TA, et al. Mucosal and hormonal adaptations after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2023; 19: 37-49.
31.
Simoneau M, McKay B, Brooks E, et al. Gut peptides before and following Roux-En-Y gastric bypass: a systematic review and meta-analysis. Obes Rev 2024; 25: e13702.
32.
Gao Z, Yang J, Liang Y, et al. Changes in gastric inhibitory polypeptide (GIP) after Roux-en-Y gastric bypass in obese patients: a meta-analysis. Obes Surg 2022; 32: 2706-16.
33.
Gu L, Lin K, Du N, et al. Differences in the effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass on gut hormones: systematic and meta-analysis. Surg Obes Relat Dis 2021; 17: 444-55.
34.
Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244: 741-9.
35.
Kirwan JP, Axelrod CL, Kullman EL, et al. Foregut exclusion enhances incretin and insulin secretion after Roux-en-Y gastric bypass in adults with type 2 diabetes. J Clin Endocrinol Metab 2021; 106: e4192-201.
36.
Steenackers N, Vanuytsel T, Augustijns P, et al. Adaptations in gastrointestinal physiology after sleeve gastrectomy and Roux-en-Y gastric bypass. Lancet Gastroenterol Hepatol 2021; 6: 225-37.
37.
Debédat J, Clément K, Aron-Wisnewsky J. Gut microbiota dysbiosis in human obesity: impact of bariatric surgery. Curr Obes Rep 2019; 8: 229-42.
38.
Yamamoto H, Kaida S, Yamaguchi T, et al. Potential mechanisms mediating improved glycemic control after bariatric/metabolic surgery. Surg Today 2016; 46: 268-74.
39.
Pérez-Pevida B, Escalada J, Miras AD, Frühbeck G. Mechanisms underlying type 2 diabetes remission after metabolic surgery. Front Endocrinol (Lausanne) 2019; 10: 641.
40.
Gentileschi P, Bianciardi E, Benavoli D, Campanelli M. Metabolic surgery for type II diabetes: an update. Acta Diabetol 2021; 58: 1153-9.
